HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 196 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $310,000 | -92.6% | 18,355 | -91.5% | 0.08% | -85.5% |
| Q1 2018 | $4,210,000 | +266.1% | 214,887 | +278.5% | 0.59% | +324.6% |
| Q4 2017 | $1,150,000 | +55.6% | 56,773 | +33.4% | 0.14% | +70.4% |
| Q3 2017 | $739,000 | +84.3% | 42,573 | +36.1% | 0.08% | +65.3% |
| Q2 2017 | $401,000 | +2.8% | 31,273 | +4.0% | 0.05% | +2.1% |
| Q1 2017 | $390,000 | +124.1% | 30,073 | +71.1% | 0.05% | +54.8% |
| Q4 2016 | $174,000 | -17.9% | 17,573 | 0.0% | 0.03% | -38.0% |
| Q3 2016 | $212,000 | +29.3% | 17,573 | -7.4% | 0.05% | +22.0% |
| Q2 2016 | $164,000 | -65.0% | 18,973 | -61.7% | 0.04% | -73.0% |
| Q1 2016 | $469,000 | -23.5% | 49,573 | +40.0% | 0.15% | -58.8% |
| Q4 2015 | $613,000 | – | 35,400 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |